Well-defined diimine copper(I) complexes as catalysts in click azide-alkyne cycloaddition reactions.

A series of 1,4-disubstituted 1,2,3-triazoles have been prepared in high yields while respecting the stringent Click criteria. In these reactions, highly stable pre-formed complexes bearing diimine ligands were used.

1. Introduction

The introduction of copper(I) catalysts in the cycloaddition of azides and terminal alkynes represents one of the latest success stories of organometallic catalysis [1,2,3,4]. Not only is this transformation high yielding and completely regioselective, but also it exemplifies the utility and importance of Click chemistry [5]. Whereas this cycloaddition reaction has been applied in a plethora of fields, the efforts to develop efficient catalytic systems, respectful of the Click criteria, have been significantly fewer. Nevertheless, the use of ligands in the cycloaddition of alkynes and azides has been shown to stabilize the copper(I) centre, increase the catalytic activity, and even modulate it [6]. Among the different families of ligands applied in this reaction, nitrogen-based ones are arguably the most widely used. Whereas Meldal et al. used diisopropylethylamine in their groundbreaking report [1], N,N',N''-pentametyletylentriamine (PMDETA) and tris-triazoles are also very popular choices [6]. However, examples of well-defined catalysts containing nitrogen based remain scarce [7,8,9,10,11]. Most reported examples employ polydentate ligands such as polytriazoles or tren ligands (Figure 1). Particularly relevant to this work are complexes bearing bis(aryl)acenaphthenenquinonediimine (Ar-BIAN) ligands C. These have been shown to lead to the formation of triazoles in conversion ranging from modest to good in THF at 50 °C [11].

Figure 1

Reported preformed copper(I) catalysts with N-ligands.

Herein, we report the catalytic activity of pre-formed copper(I) complexes bearing one or two α-diimine ligands in the preparation of 1,2,3-triazoles from azides and terminal alkynes. The structures of the screened complexes are shown in Figure 2. These complexes are all highly stable and easy to prepare from simple diazabutadiene compounds [12].

Figure 2

Copper(I) catalysts used in this study.

2. Results and Discussion

We started our optimization studies with the screening of different solvents. We chose cationic complex 1 and benzyl azide (9a) and phenylacetylene as the model reaction. Using 5 mol% of the copper catalyst, virtually no conversion of the starting materials was observed with MeCN, cyclohexane, or ethyl acetate, whereas poor results were obtained in MeOH or under neat conditions (Table 1). Satisfyingly, complete conversions into triazole 10a were obtained on water and in acetone (Table 1, entries 8 and 9). Similar results were observed in THF or in a mixture water/t-BuOH, however, reactions in these solvents were not always reproducible and they were not studied further (Table 1, entries 6 and 7).

Table 1

Solvent screening.

Entry	Solvent	[Cu] (mol%)	Conv. (%) a
1	MeCN	5	<5
2	Cyclohexane	5	<5
3	Ethyl Acetate	5	<5
4	MeOH	5	52
5	Neat	5	13
6	THF	5	84 to <5
7	Water/t-BuOH	5	>95 to 9
8	Water	5	>95
9	Acetone	5	>95
10	Water	2	52
11	Acetone	2	86

a 1H-NMR conversions are the average of at least two independent reactions.

In order to determine the best reaction medium for this reaction, the copper loading was next reduced to 2 mol% with acetone and water (Table 1, entries 10 and 11). A higher conversion of 86% was observed in acetone and hence it was kept as solvent for the rest of the study. It is important to note that all tested solvents were technical grade, and in particular, the acetone employed here was the one normally used for cleaning the glassware in the laboratory.

We next performed a catalyst screening in acetone at room temperature using 2 mol% of different diimine copper complexes (Scheme 1). All the tested complexes performed well in the model reactions with conversion ranging from 42% to complete. For complexes bearing aromatic groups on the ligands, steric hindrance proved to be more beneficial to the reaction outcome than the presence of electron donating groups. In general, cationic complexes performed better than their neutral analogues, except for complexes bearing adamantyl imine ligands 5 and 6. Additionally, the best performing complexes had aliphatic substituents on the diimine ligand(s). Hence, complexes 5, 7 and 8 led to total conversions and further experiments were run with these in order to determine the best performing one.

Scheme 1

Catalyst screening a.

First, the metal loading was further reduced (Table 2). Similar results were obtained with 1 mol% [Cu], but at 0.5 mol% [Cu] it became apparent that complexes bearing either one or two cyclohexyl diimine ligands 7 and 8 displayed a better activity than complex 5, with adamantyl substituents. Gratifyingly, complex 8 could still achieve total conversion in a more concentrated reaction (1 M rather than 0.5 M), and it was chosen as the optimal catalyst within the tested series.

Table 2

Final optimization reactions.

Entry	[Cu]	Concentration (M)	Conv. (%) a
1	5, 1 mol%	0.5	<95
2	7, 1 mol%	0.5	<95
3	8, 1 mol%	0.5	<95
4	5, 0.5 mol%	0.5	63
5	7, 0.5 mol%	0.5	92
6	8, 0.5 mol%	0.5	<95
7	7, 0.5 mol%	1.0	93
8	8, 0.5 mol%	1.0	<95

a 1H-NMR conversions are the average of at least two independent reactions.

With an optimized catalytic system in hand, the scope of the reaction was then explored. All reactions were carried out in technical grade acetone, in air and in no cases oxidation to copper(II) or disproportionation to copper(0) and copper(II) were observed. Also, no other by-products were formed and the prepared triazoles could be easily isolated as pure products in high yields after a simple extraction (Scheme 2).

Scheme 2

Preparation of 1,2,3-triazoles catalyzed by complex 8 a.

A number of functional groups were well tolerated, such as alcohols, amines, alkenes and nitriles. Benzyl, alkyl and aryl azides well suitable cycloaddition partners, as well as electron rich or electron poor alkynes. In some cases, total conversions were not reached under the optimized conditions. However, a slight increase in the reaction temperature (from RT to 40 °C) or the metal loading was enough to ensure a high isolated yield.

a Isolated yields are the average of at least two independent reactions; b 2 mol% 8; c 40 °C; d 1 mol% 8.

3. Experimental Section

3.1. General

All reagents were commercially available and used as received. 1H-NMR (400 MHz) and 13C-NMR (100 MHz) spectra were recorded in CDCl3 on a Bruker AVANCE400 spectrometer at room temperature. Chemical shifts (δ) are reported in ppm and referenced to tetramethylsilane (1H) and deuterated chloroform (13C), respectively. All reactions were carried out in air and using technical solvents with no particular precautions to exclude oxygen or moisture. All reported yields are isolated yields and are the average of at least two independent reactions. Benzyl azide (9a) [13] 2-azidoethyl-diisopropylamine (9b) [14], 2-(2-azidoethyl)-1,3-dioxolane (9c) [15], (2-azidoethyl)benzene (9d) [13], 3-(azidoprop-1-en-yl)benzene (9e) [16], phenyl azide (9f) [17], 6-azidohexanenitrile (9g) [18] and (1-azidoethy)benzene (9h) [13] are known in the literature and the corresponding spectroscopic data for all these compounds were in good agreement with the reported data.

3.2. Catalytic Results

General Procedure for the [3+2] Cycloaddition of Azides and Terminal Alkynes

In a vial fitted with a screw cap, azide 9 (1 mmol), alkyne (1 mmol), acetone (1 mL) and 8 (3 mg, 0.5 mol%) were loaded. The reaction was allowed to proceed at room temperature overnight (20 h). The reaction mixture was then hydrolyzed with a saturated aqueous solution of NH4Cl (1 h) and extracted with EtOAc. In all examples, the crude products were estimated to be greater than 95% pure by 1H-NMRs.

1-Benzyl-4-phenyl-1H-1,2,3-triazole (10a). Using the general procedure 223 mg (95%) of the title compound were prepared from benzyl azide (9a, 125 μL) and phenylacetylene (112 μL). Spectroscopic data for 10a were consistent with previously reported data for this compound [19]. 1H-NMR (CDCl3): δ 7.80 (d, J = 7.0 Hz, 2H, HAr), 7.66 (s, 1H, NCH = C), 7.42–7.37 (m, 5H, HAr), 7.34–7.31 (m, 3H, HAr), 5.59 (s, 2H, PhCH2). 13C-NMR (CDCl3): δ 148.2 (C, =C–Ph), 134.7 (C, CAr), 130.5 (C, CAr), 129.1 (CH, CHAr), 128.8 (CH, CHAr), 128.8 (CH, CHAr), 128.1 (CH, CHAr), 128.0 (CH, CHAr), 125.7 (CH, CHAr), 119.5 (CH, NCH=), 54.2 (CH2).

1-Benzyl-4-butyl-1H-1,2,3-triazole (10b). Using the general procedure 199 mg (92%) of the title compound were prepared from benzyl azide (9a, 125 μL), 1-hexyne (115 μL), and 8 (12 mg, 2 mol%) at 40 °C, Spectroscopic data for 10b were consistent with previously reported data for this compound [10]. 1H-NMR (CDCl3): δ 7.40–7.34 (m, 3H, HAr), 7.26–7.24 (m, 2H, HAr), 7.18 (s, 1H, NCH=C), 5.50 (s, 2H, PhCH2N), 2.69 (t, J = 7.5 Hz, 2H, C=CNCH2), 1.62 (quintet, J = 7.5 Hz, 2H, CH2CH2CH2), 1.37 (sextet, J = 7.3 Hz, 2H, CH2CH3), 0.91 (t, J = 7.3 Hz, 3H, CH3). 13C-NMR (CDCl3): δ 149.8 (C, NC=C-butyl), 135.0 (C, CAr), 129.0 (CH, CHAr), 128.6 (CH, CHAr), 127.9 (CH, CHAr), 120.9 (CH, NCH=), 54.0 (CH2, PhCH2), 31.4 (CH2), 25.4 (CH2), 22.3 (CH2), 13.8 (CH3).

1-Benzyl-4-(2-hydroxypropan-2-yl)-1H-1,2,3-triazole (10c). Using the general procedure 183 mg (84%) of the title compound were prepared from benzyl azide (9a, 125 μL), 2-methylbut-3-yn-2-ol (100 μL), and 8 (6 mg, 1 mol%) at 40 °C. Spectroscopic data for 10c were consistent with previously reported data for this compound [19]. 1H-NMR (CDCl3): 7.39–7.35 (m, 3H, HAr), 7.34 (s, 1H, NCH=C), 7.31–7.27 (m, 2H, HAr), 5.51 (s, 2H, CH2), 2.34 (br s, 1H, OH), 1.61 (s, 6H, CH3). 13C-NMR (CDCl3): δ 156.0 (C, NC=C–), 134.6 (C, CAr), 129.2 (CH, CHAr), 128.6, (CH, CHAr), 128.2 (CH, CHAr), 119.1 (CH, NCH=), 68.3 (C, C(OH)Me2), 54.2 (CH2, PhCH2), 30.5 (CH3).

1-(2-Diisopropylaminoethyl)-4-phenyl-1H-1,2,3-triazole (10d). Using the general procedure 232 mg (85%) of the title compound were prepared from azide 9b (170 mg) and phenylacetylene (112 μL). 1H-NMR (CDCl3): δ 7.84–7.81 (m, 3H, HAr), 7.45 (t, J = 6.4 Hz, 2H, HAr), 7.35 (t, J = 6.4 Hz, 1H, HAr), 4.38 (t, J = 6.5 Hz, 2H, CH2), 3.04 (septet, J = 6.5 Hz, 2H, CH(CH3)2), 2.95 (t, J = 6.5 Hz, 2H, CH2), 0.99 (d, J = 6.5 Hz, 12H, CH3); 13C-NMR (CDCl3): δ 147.1 (NCH=C), 130.9 (C, CAr), 128.8 (CH, CHAr), 127.9 (CH, CHAr), 125.7 (CH, CHAr), 120.8 (CH, NCH=), 51.2 (CH2, CH2N), 48.7 (CH, CHN), 45.7 (CH2, CH2N), 20.8 (CH3). HRMS calculated for C16H25N4: 273.2079; found 273.2086 [(M+H)+].

Ethyl 1-(2-(1,3-dioxolan-2-yl)ethyl)-1H-1,2,3-triazole-4-carboxylate (10e). Using the general procedure 203 mg (84%) of the title compound were prepared from azide 9c (143 mg), ethyl propiolate (102 μL), and 8 (6 mg, 1 mol%). Spectroscopic data for 10e were consistent with previously reported data for this compound [20]. 1H-NMR (CDCl3): δ 8.12 (s, 1H, NCH=C), 4.93 (t, J = 4.0 Hz, 1H, OCHO), 4.58 (t, J = 7.0 Hz, 2H, CH2CH2N), 4.43 (q, J = 7.0 Hz, OCH2CH3), 4.03–3.93 (m, 2H, OCH2CH2O), 3.93–3.83 (m, 2H, OCH2CH2O), 2.33 (dt, J = 4.0; 7.0 Hz, CHCH2CH2), 1.41 (t, J = 7.0 Hz, 3H, OCH2CH3). 13C-NMR (CDCl3): δ 160.2 (C, C=O), 139.3 (C, =C–CO2Et), 127.5 (CH, CH=C), 127.5 (CH, O–CH–O), 64.55 (CH2, O–CH2–CH2–O), 64.48 (CH2, O–CH2–CH2–O), 60.6 (CH2, OCH2–CH3), 45.0 (CH2, CH2–CH2–N), 33.2 (CH2, CH2–CH2–N), 13.7 (CH3).

N,N-Dimethyl-1-(1-phenethyl-1H-1,2,3-triazol-4-yl)methanamine (10f). Using the general procedure 202 mg (88%) of the title compound were prepared from (2-azidoethyl)benzene (9d, 147 mg), dimethylprop-2-ynylamine (111 μL) and 8 (6 mg, 1 mol%). Spectroscopic data for 10f were consistent with previously reported data for this compound [20]. 1H-NMR (CDCl3): δ 7.31–7.21 (m, 4H, HAr + NCH=C), 7.09 (d, J = 7.0 Hz, 2H, HAr), 4.58 (t, J = 7.0 Hz, 2H, PhCH2CH2), 3.57 (s, 2H, CH2NMe2), 3.21 (t, J = 7.0 Hz, 2H, PhCH2CH2), 2.23 (s, 6H, NMe2). 13C-NMR (CDCl3): δ 144.7 (C, NCH=C), 137.0 (C, CAr), 128.7 (CH, CHAr), 128.6 (CH, CHAr), 126.9 (CH, CHAr), 122.6 (CH, NCH=), 54.2 (CH2, PhCH2CH2N), 51.4 (CH2, CH2NMe2), 44.9 (CH2, PhCH2), 36.6 (CH3).

4-Phenyl-1-(3-phenyl-2-propenyl)-1H-1,2,3-triazole (10g). Using the general procedure 250 mg (96%) of the title compound were prepared from azide 9e (159 mg) and phenylacetylene (112 μL). Spectroscopic data for 10g were consistent with previously reported data for this compound [21]. 1H-NMR (CDCl3): δ 7.84–7.82 (m, 3H, HAr + NCH=C), 7.43–7.39 (m, 4H, HAr), 7.36–7.32 (m, 4H, HAr), 6.72 (d, J = 16.0 Hz, 1H, PhCH=CH), 6.40 (dt, J = 16.0, 6.5 Hz, 1H, PhCH=CH), 5.20 (d, J = 6.5 Hz, 2H, CH2N). 13C-NMR (CDCl3): δ 148.0 (C, NCH=C), 135.4 (C, CAr), 135.2 (CH, CHAr), 130.5 (C, CAr), 128.7 (CH, CHAr), 128.6 (CH, CHAr), 128.4 (CH, CHAr), 128.0 (CH, CHAr), 126.6 (CH, PhCH=), 125.6 (CH, PhCH=CH), 121.8 (CH, CHAr), 119.3 (CH, NCH=), 52.3 (CH2, CH2N).

Dimethyl(1-phenyl-1H-1,2,3-triazol-4-ylmethyl)amine (10h). Using the general procedure 196 mg (97%) of the title compound were prepared from phenyl azide (9f, 107 μL) and dimethylprop-2-ynylamine (111 μL). Spectroscopic data for 10h were consistent with previously reported data for this compound [22]. 1H-NMR (CDCl3): δ 7.95 (s, 1H, NCH=C), 7.74 (d, J = 8.0 Hz, 2H, HAr), 7.53 (t, J = 8.0, 2H, HAr), 7.43 (t, J = 8.0 Hz, 1H, HAr), 3.71 (s, 2H, CH2NMe2), 2.34 (s, 6H, NMe2). 13C-NMR (CDCl3): δ 146.0 (C, NCH=C), 137.0 (C, CAr), 129.6 (CH, CHAr), 128.5 (CH, CHAr), 120.4 (CH, NCH=), 120.3 (CH, CHAr), 54.3 (CH2, CH2N), 45.2 (CH3).

6-(4-Phenyl-1,2,3-triazol-1-yl)hexanenitrile (10i). Using the general procedure 227 mg (94%) of the title compound were prepared from 6-azidohexanenitrile (9g, 138 mg) and phenylacetylene (112 μL). Spectroscopic data for 10i were consistent with previously reported data for this compound [23]. 1H-NMR (CDCl3): δ 7.85–7.82 (m, 2H, HAr), 7.76 (s, 1H, NCH=), 7.45–7.42 (m, 2H, HAr), 7.36–7.31 (m, 1H, HAr), 4.44 (t, J = 7.0 Hz, 2H, CH2N), 2.36 (t, J = 7.0 Hz, 2H, CH2CN), 2.08–1.97 (m, 2H,CH2), 1.77–1.67 (m, 2H,CH2), 1.59–1.48 (m, 2H, CH2). 13C-NMR (CDCl3): δ 147.8 (C, C=C–Ph), 130.5 (C, CAr), 128.8 (CH, CAr), 128.1 (CH, CAr), 125.6 (CH, CAr), 119.5 (CH, CH=C–Ph), 119.3 (C, CN), 49.8 (CH2, CH2–N), 29.5 (CH2), 25.5 (CH2), 24.7 (CH2), 17.0 (CH2).

4-Cyclopropyl-1-(1-phenylethyl)-1H-1,2,3-triazole (10j). Using the general procedure 183 mg (85%) of the title compound were prepared from azide 9h (147 mg), ethynylcyclopropane (87 μL) and 8 (6 mg, 1 mol%) at 40 °C. Spectroscopic data for 10j were consistent with previously reported data for this compound [23]. 1H-NMR (CDCl3): δ 7.40–7.28 (m, 3H, HAr), 7.27–7.24 (m, 2H, HAr), 7.11 (s, 1H, NCH=C), 5.76 (q, 1H, J = 7.0 Hz, PhCH), 1.95 (d, 3H, J = 7.0 Hz, CH3), 1.93–1.87 (m, 1H, CHcyclopropyl), 0.94–0.87 (m, 2H, CH2), 0.84–0.79 (m, 2H, CH2). 13C-NMR (CDCl3): δ 150.2 (C=Ccyclopropyl), 140.1 (C, CAr), 128.9 (CH, CHAr), 128.3 (CH, CHAr), 126.4 (CH, CHAr), 118.3 (CH, N–CH=C), 58.9 (CH, PhCH), 21.2 (CH3), 7.6 (CH, CHcyclopropyl), 6.7 (CH2, CH2).

4. Conclusions

Diimine copper(I) complexes are highly efficient catalysts for the [3+2] cycloaddition of azides and terminal alkynes. Low copper loadings were enough to ensure high isolated yields of 1,2,3-triazoles at room temperature, in air and in technical grade acetone. Furthermore, purification by column chromatography was not necessary, and a simple extraction was enough to isolate pure triazoles. The reported catalysts are noticeably more active than related Ar-BIAN complexes. This might be attributed to two factors: (1) the presence of alkyl groups on the diimine ligands; which in these series systematically outperformed aryl diimines; or (2) the increased chemical stability of simple diimine scaffolds, in particular towards oxidation and reduction reactions.